U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07532707) titled 'Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.' on March 31.
Brief Summary: This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress.
Study Start Date: Sept. 01, 2022
Study Type: INTERVENTIONAL
Condition:
Myasthenic Crisis
Myasthenia Gravis (MG)
Intervent...